TXN
Basic information
Region (hg38): 9:110243810-110256507
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TXN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 2 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 1 | 1 | 0 |
Variants in TXN
This is a list of pathogenic ClinVar variants found in the TXN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-110244173-A-G | not specified | Uncertain significance (Nov 13, 2023) | ||
9-110251438-C-T | not specified | Likely benign (Mar 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TXN | protein_coding | protein_coding | ENST00000374517 | 5 | 12830 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.201 | 0.759 | 125704 | 0 | 3 | 125707 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.14 | 30 | 53.4 | 0.562 | 0.00000254 | 699 |
Missense in Polyphen | 4 | 9.584 | 0.41736 | 167 | ||
Synonymous | 0.142 | 18 | 18.8 | 0.958 | 0.00000111 | 175 |
Loss of Function | 1.71 | 2 | 6.82 | 0.293 | 2.88e-7 | 85 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000177 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Participates in various redox reactions through the reversible oxidation of its active center dithiol to a disulfide and catalyzes dithiol-disulfide exchange reactions. Plays a role in the reversible S-nitrosylation of cysteine residues in target proteins, and thereby contributes to the response to intracellular nitric oxide. Nitrosylates the active site Cys of CASP3 in response to nitric oxide (NO), and thereby inhibits caspase-3 activity. Induces the FOS/JUN AP-1 DNA-binding activity in ionizing radiation (IR) cells through its oxidation/reduction status and stimulates AP-1 transcriptional activity.;
- Pathway
- NOD-like receptor signaling pathway - Homo sapiens (human);Fluid shear stress and atherosclerosis - Homo sapiens (human);Oxidative Stress Regulatory Pathway (Erythrocyte);Purine Nucleoside Phosphorylase Deficiency;Mercaptopurine Action Pathway;Azathioprine Action Pathway;Xanthine Dehydrogenase Deficiency (Xanthinuria);Adenylosuccinate Lyase Deficiency;AICA-Ribosiduria;Thioguanine Action Pathway;Adenine phosphoribosyltransferase deficiency (APRT);Mitochondrial DNA depletion syndrome;Myoadenylate deaminase deficiency;Purine Metabolism;Molybdenum Cofactor Deficiency;Adenosine Deaminase Deficiency;Gout or Kelley-Seegmiller Syndrome;Lesch-Nyhan Syndrome (LNS);Xanthinuria type I;Xanthinuria type II;Selenium Micronutrient Network;TNF alpha Signaling Pathway;Human Complement System;Nuclear Receptors Meta-Pathway;NRF2 pathway;VEGFA-VEGFR2 Signaling Pathway;Detoxification of Reactive Oxygen Species;Gene expression (Transcription);Generic Transcription Pathway;Oxidative Stress Induced Senescence;The NLRP3 inflammasome;Metabolism of nucleotides;Cellular Senescence;Inflammasomes;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Cellular responses to stress;Metabolism of proteins;Interconversion of nucleotide di- and triphosphates;RNA Polymerase II Transcription;Protein repair;Innate Immune System;Immune System;Metabolism;TP53 Regulates Metabolic Genes;Cellular responses to external stimuli;Transcriptional Regulation by TP53;TNFalpha;TNF receptor signaling pathway ;p38 MAPK signaling pathway;Signaling events mediated by PTP1B
(Consensus)
Recessive Scores
- pRec
- 0.729
Intolerance Scores
- loftool
- 0.260
- rvis_EVS
- 0.01
- rvis_percentile_EVS
- 54.63
Haploinsufficiency Scores
- pHI
- 0.346
- hipred
- Y
- hipred_score
- 0.567
- ghis
- 0.520
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.973
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Txn1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; cellular phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;glycerol ether metabolic process;signal transduction;cell-cell signaling;cell population proliferation;response to radiation;activation of protein kinase B activity;positive regulation of peptidyl-serine phosphorylation;obsolete regulation of protein import into nucleus, translocation;positive regulation of DNA binding;cell redox homeostasis;negative regulation of protein export from nucleus;positive regulation of protein kinase B signaling;oxidation-reduction process;negative regulation of hydrogen peroxide-induced cell death
- Cellular component
- nucleus;cytosol;extracellular exosome
- Molecular function
- RNA binding;protein binding;protein disulfide oxidoreductase activity;peptide disulfide oxidoreductase activity